Clinically relevant dysregulated pathways in GBM
Clinically relevant dysregulated pathways in GBM. EGFR, PDGFRA and MET are some of the most common RTK receptors mutated and/or amplified in GBM. These mutations and/or amplifications alter downstream signaling pathways responsible for tumor growth and survival. GBMs with these receptor modifications can activate the RAS signaling pathway, promoting cell proliferation and survival while retaining mutations in the inhibitory protein of RAS, NF1. PI3K signaling is also upregulated by these receptor alterations, while also harboring alterations in the signaling pathway itself. In its wild-type form, PTEN inhibits conversion of PIP2 to PIP3. When mutated, it activates a downstream cascade of signaling pathways. Increase in Akt activity inhibits FOXO, assisting in uncontrolled cell proliferation. While Mouse Double Minute 2 (MDM2) has an increase in activity due to the increase in Akt activity, MDM2 is also amplified in ~14% of GBMs. MDM2 is typically inhibited by CDKN2A in response to activated oncogenic genes/signals, but CDKN2A is mutated in ~50% of GBMs. MDM2 inhibits p53 while the p53 gene itself is identified to have mutations in ~28% of GBMs. The inhibition of p53 due to mutations and/or increased activity of MDM2 prevents p53 from sending cells into apoptosis, leading to tumor growth and survival. The protein mTOR is also activated by Akt which promotes the cell cycle, leading to phosphorylation of Rb, which allows activation of E2F, thus promoting cell proliferation. The Rb signaling pathway is also known to be altered in almost 80% of GBMs. The image was created using BioRender.com. GBM, glioblastoma; RTK, receptor tyrosine kinase; NF1, neurofibromin 1; PTEN, phosphatase and tensin homolog; Rb, retinoblastoma
Publication
Targeting drug resistance in glioblastoma (Review) (2024) Jonathan H. Sherman, et al. Int J Oncol. 2024 Aug;65(2). Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | EGFR | EGFR | ncbigene_symbol | EGFR | 1956 |
| Homo sapiens | Primates | PDGFRA | PDGFRA | ncbigene_symbol | PDGFRA | 5156 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | NF1 | NF1 | ncbigene_symbol | NF1 | 4763 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | KRAS | 3845 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | HRAS | 3265 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | NRAS | 4893 |
| Homo sapiens | Primates | CDKN2A | CDKN2A | ncbigene_symbol | CDKN2A | 1029 |
| Homo sapiens | Primates | PTEN | PTEN | ncbigene_symbol | PTEN | 5728 |
| Homo sapiens | Primates | Akt | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | Akt | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | Akt | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | MDM2 | MDM2 | ncbigene_symbol | MDM2 | 4193 |
| Homo sapiens | Primates | CyclinD | CYCLIND | famplex_relations | CCND1 | 595 |
| Homo sapiens | Primates | CyclinD | CYCLIND | famplex_relations | CCND2 | 894 |
| Homo sapiens | Primates | CyclinD | CYCLIND | famplex_relations | CCND3 | 896 |
| Homo sapiens | Primates | CDK4/6 | CDK4 | ncbigene_symbol | CDK4 | 1019 |
| Homo sapiens | Primates | CDK4/6 | CDK6 | ncbigene_symbol | CDK6 | 1021 |
| Homo sapiens | Primates | E2F | E2F | famplex_relations | E2F1 | 1869 |
| Homo sapiens | Primates | E2F | E2F | famplex_relations | E2F2 | 1870 |
| Homo sapiens | Primates | E2F | E2F | famplex_relations | E2F3 | 1871 |
| Homo sapiens | Primates | E2F | E2F | famplex_relations | E2F4 | 1874 |
| Homo sapiens | Primates | E2F | E2F | famplex_relations | E2F5 | 1875 |
| Homo sapiens | Primates | E2F | E2F | famplex_relations | E2F6 | 1876 |
| Homo sapiens | Primates | E2F | E2F | famplex_relations | E2F7 | 144455 |
| Homo sapiens | Primates | E2F | E2F | famplex_relations | E2F8 | 79733 |
| Homo sapiens | Primates | mTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Homo sapiens | Primates | FOXO | FOXO | famplex_relations | FOXO1 | 2308 |
| Homo sapiens | Primates | FOXO | FOXO | famplex_relations | FOXO3 | 2309 |
| Homo sapiens | Primates | FOXO | FOXO | famplex_relations | FOXO4 | 4303 |
| Homo sapiens | Primates | FOXO | FOXO | famplex_relations | FOXO6 | 100132074 |
| Homo sapiens | Primates | p53 | P53 | ncbigene_synonym | TP53 | 7157 |
| Homo sapiens | Primates | p53 | P53 | famplex_relations | TP63 | 8626 |
| Homo sapiens | Primates | p53 | P53 | famplex_relations | TP73 | 7161 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| MET | Met | methionine | chebi:16811 | |
| RAS | RAS | (1R)-N-(prop-2-yn-1-yl)indan-1-amine | chebi:63620 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|